Periodic Reporting for period 3 - AB-DiRecT (Antibiotic Distribution and Recovery in Tissue)

Gepotidacin is a novel antibiotic currently in Phase 3 development by GlaxoSmithKline Pharmaceuticals (GSK) as a potential treatment for uncomplicated urinary tract infection and uncomplicated gonorrhea. The distribution of this antibiotic in peripheral tissues after systemic...